- Home
- Publications
- Publication Search
- Publication Details
Title
Principles of a new treatment algorithm in multiple sclerosis
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume 11, Issue 3, Pages 351-362
Publisher
Informa UK Limited
Online
2011-03-08
DOI
10.1586/ern.11.15
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Progressive multifocal leukoencephalopathy: Can we reduce risk in patients receiving biological immunomodulatory therapies?
- (2010) Kenneth L. Tyler ANNALS OF NEUROLOGY
- Anti-JC virus antibodies: Implications for PML Risk Stratification
- (2010) Leonid Gorelik et al. ANNALS OF NEUROLOGY
- Natalizumab and Progressive Multifocal Leukoencephalopathy
- (2010) Clemens Warnke et al. ARCHIVES OF NEUROLOGY
- Immune Reconstitution Inflammatory Syndrome in Patients With Multiple Sclerosis Following Cessation of Natalizumab Therapy
- (2010) Augusto Miravalle et al. ARCHIVES OF NEUROLOGY
- Natalizumab induces a rapid improvement of disability status and ambulation after failure of previous therapy in relapsing-remitting multiple sclerosis
- (2010) S. Belachew et al. EUROPEAN JOURNAL OF NEUROLOGY
- PEGylated Interferon Beta-1a: Meeting an Unmet Medical Need in the Treatment of Relapsing Multiple Sclerosis
- (2010) Darren P. Baker et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Oral therapies for multiple sclerosis: are we there yet?
- (2010) Hans-Peter Hartung et al. LANCET NEUROLOGY
- Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis
- (2010) Chris H Polman et al. LANCET NEUROLOGY
- Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial
- (2010) Mads Ravnborg et al. LANCET NEUROLOGY
- Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta
- (2010) Daniel Wynn et al. LANCET NEUROLOGY
- Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases
- (2010) David B Clifford et al. LANCET NEUROLOGY
- Atorvastatin Combined To Interferon to Verify the Efficacy (ACTIVE) in relapsing— remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy
- (2010) Roberta Lanzillo et al. Multiple Sclerosis Journal
- Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
- (2010) Volker Brinkmann et al. NATURE REVIEWS DRUG DISCOVERY
- Fingolimod is a potential novel therapy for multiple sclerosis
- (2010) Orhan Aktas et al. Nature Reviews Neurology
- A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
- (2010) Gavin Giovannoni et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosis
- (2010) Orhan Aktas et al. TRENDS IN NEUROSCIENCES
- Magnetic Resonance Imaging Predictors of Conversion to Multiple Sclerosis in the BENEFIT Study
- (2009) Bastiaan Moraal et al. ARCHIVES OF NEUROLOGY
- Immunosuppressive Drugs in Kidney Transplantation
- (2009) Roberto Marcén DRUGS
- Efficacy of natalizumab in multiple sclerosis patients with high disease activity: a Danish nationwide study
- (2009) A. B. Oturai et al. EUROPEAN JOURNAL OF NEUROLOGY
- Efficacy of natalizumab in second line therapy of relapsing-remitting multiple sclerosis: results from a multi-center study in German speaking countries
- (2009) N. Putzki et al. EUROPEAN JOURNAL OF NEUROLOGY
- Long-term experience with induction treatment regimens in multiple sclerosis
- (2009) Emmanuelle Le Page et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Immunosuppression followed by immunomodulation
- (2009) Mike Boggild JOURNAL OF THE NEUROLOGICAL SCIENCES
- Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial
- (2009) G Comi et al. LANCET
- NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial
- (2009) Per Soelberg Sorensen et al. LANCET NEUROLOGY
- Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study
- (2009) Eva Havrdova et al. LANCET NEUROLOGY
- 250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study
- (2009) Paul O'Connor et al. LANCET NEUROLOGY
- Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required
- (2009) Ana M Pascual et al. Multiple Sclerosis Journal
- Efficacy of intramuscular interferon beta-1a in patients with clinically isolated syndrome: analysis of subgroups based on new risk criteria
- (2009) P O’Connor et al. Multiple Sclerosis Journal
- Glatiramer acetate in combination with minocycline in patients with relapsing—remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial
- (2009) LM Metz et al. Multiple Sclerosis Journal
- Mitoxantrone: benefits and risks in multiple sclerosis patients
- (2009) V. Martinelli et al. NEUROLOGICAL SCIENCES
- Efficacy of treatment of MS with IFN -1b or glatiramer acetate by monthly brain MRI in the BECOME study
- (2009) D. Cadavid et al. NEUROLOGY
- GLANCE: Results of a phase 2, randomized, double-blind, placebo-controlled study
- (2009) A. D. Goodman et al. NEUROLOGY
- Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS
- (2009) J. A. Cohen et al. NEUROLOGY
- Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis
- (2008) L. K. Fisniku et al. BRAIN
- Therapeutic outcome 3 years after switching of immunomodulatory therapies in patients with relapsing–remitting multiple sclerosis in Argentina
- (2008) A. Carrá et al. EUROPEAN JOURNAL OF NEUROLOGY
- Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
- (2008) G Comi et al. LANCET
- Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
- (2008) Ludwig Kappos et al. LANCET
- Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial
- (2008) Daniel D Mikol et al. LANCET NEUROLOGY
- Switching first-line disease-modifying therapy after failure: impact on the course of relapsing–remitting multiple sclerosis
- (2008) A Gajofatto et al. Multiple Sclerosis Journal
- Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More